Acute coronary syndromes: 6c-Patients discharged on lipid-lowering therapy
Identifying and definitional attributes | |
Metadata item type:![]() | Indicator |
---|---|
Indicator type:![]() | Indicator |
Short name:![]() | Indicator 6c-Patients discharged on lipid-lowering therapy |
METeOR identifier:![]() | 612087 |
Registration status:![]() | Health, Standard 12/09/2016 |
Description:![]() | Proportion of patients with a final diagnosis of acute coronary syndrome (ACS) who are prescribed lipid-lowering therapy at separation from hospital. |
Rationale:![]() | Lowering lipid levels (using statins) is an effective primary and secondary prevention treatment for vascular events, including stroke (Amarenco et al. 2006). |
Indicator set:![]() | Clinical care standard indicators: acute coronary syndromes Health, Standard 12/09/2016 |
Outcome area:![]() | Individualised care plan Health, Standard 12/09/2016 |
Collection and usage attributes | |
Computation description:![]() | Both the numerator and the denominator include patients with acute chest pain, or other symptoms suggestive of ACS. The denominator excludes statin-intolerant ACS patients, and other ACS patients for whom statins or other lipid-lowering therapies are contraindicated and for whom the contraindication is documented. Contraindications for statins may include advance care directives, being on a palliative care pathway, and clinical judgement, subject to discussion with patients, family and carers. Presented as a percentage. |
Computation:![]() | (Numerator ÷ denominator) x 100 |
Numerator:![]() | Number of patients with a final diagnosis of ACS who are prescribed a statin or other lipid-lowering therapy at separation from hospital. |
Denominator:![]() | Number of patients with a final diagnosis of ACS who are separated from hospital. |
Representational attributes | |
Representation class:![]() | Percentage |
Data type:![]() | Real |
Unit of measure:![]() | Episode |
Format:![]() | N[NN] |
Source and reference attributes | |
Submitting organisation:![]() | Australian Commission on Safety and Quality in Health Care |
Reference documents:![]() | Amarenco P et al. 2006. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355(6):549–559. |
- My items contains 0 items
- Add item to My items
- Clear all items from My items
- Manage My items
- Download metadata item as Word™ or PDF
- Advanced options